Vanda Pharmaceuticals VNDA
$ 4.77
3.02%
Quarterly report 2024-Q3
added 11-07-2024
Vanda Pharmaceuticals General and Administrative Expenses 2011-2024 | VNDA
Annual General and Administrative Expenses Vanda Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
113 M | 136 M | 124 M | 141 M | 130 M | 106 M | 124 M | 99.8 M | 84.5 M | 84.6 M | 24.6 M | 13.9 M | 11.5 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
141 M | 11.5 M | 91.7 M |
Quarterly General and Administrative Expenses Vanda Pharmaceuticals
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
37.6 M | 39.5 M | - | 24.8 M | 28.4 M | 36.1 M | - | 29.9 M | 33 M | 40.8 M | - | 32.5 M | 28.3 M | 29.8 M | - | 34 M | 33.9 M | 37 M | - | 30.2 M | 31.5 M | 31 M | - | 26 M | 28 M | 26.8 M | - | 31.1 M | 31.4 M | 30.3 M | - | 21.9 M | 24.7 M | 29.3 M | - | 18.5 M | 18.4 M | 18.8 M | - | 11.3 M | 28.1 M | 27.9 M | - | 5.71 M | 5.07 M | 3.96 M | - | 3.15 M | 3.6 M | 3.91 M | - | 2.71 M | 2.57 M | 2.86 M |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
40.8 M | 2.57 M | 23.5 M |